Nuvation Bio, Inc. (NUVB)
4.78
+0.03
(+0.63%)
USD |
NYSE |
May 29, 16:00
4.75
-0.03
(-0.63%)
Pre-Market: 20:00
Nuvation Bio Total Assets (Quarterly) : 610.24M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| SIGA Technologies, Inc. | 219.39M |
| Merck & Co., Inc. | 128.68B |
| Pfizer Inc. | 207.62B |
| Harrow, Inc. | 419.54M |
| Alumis, Inc. | 671.59M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 290.68M |
| Shareholders Equity (Quarterly) | 319.56M |
| Debt to Equity Ratio | 0.679 |
| Current Ratio | 7.439 |
| Net Debt Paydown Yield | -2.79% |